Show simple item record

dc.contributor.authorCamilleri, M.
dc.contributor.authorSive, J.
dc.contributor.authorWilson, W.
dc.contributor.authorPang, G.
dc.contributor.authorJenner, R.
dc.contributor.authorPhillips, Elizabeth H
dc.contributor.authorPopat, R.
dc.contributor.authorRamasamy, K.
dc.contributor.authorBygrave, C.
dc.contributor.authorDadaga, T.
dc.contributor.authorStreetly, M.
dc.contributor.authorCavenagh, J.
dc.contributor.authorChapman, M.
dc.contributor.authorBarrington, S.
dc.contributor.authorPike, L.
dc.contributor.authorOwen, R.
dc.contributor.authorClifton-Hadley, L.
dc.contributor.authorYong, K.
dc.date.accessioned2021-01-06T11:15:29Z
dc.date.available2021-01-06T11:15:29Z
dc.date.issued2020en
dc.identifier.citationCamilleri M, Sive J, Wilson W, Pang G, Jenner R, Phillips E, et al. COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial. Br J Haematol. 2021;192(1):e14-e6.en
dc.identifier.pmid33222153en
dc.identifier.doi10.1111/bjh.17168en
dc.identifier.urihttp://hdl.handle.net/10541/623661
dc.description.abstractNoneen
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1111/bjh.17168en
dc.titleCOVID-19 and myeloma clinical research - experience from the CARDAMON clinical trialen
dc.typeArticleen
dc.contributor.departmentHaematology Department, University College Hospitals, London, UK.en
dc.identifier.journalBritish Journal of Haematologyen
dc.description.noteen]
refterms.dateFOA2021-01-11T10:12:34Z


Files in this item

Thumbnail
Name:
33222153.pdf
Size:
387.3Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record